A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge

Science Translational Medicine

Volumn 4, Issue 146, 2012, Pages

  Bossart, Katharine N ^a   Rockx, Barry ^b,c   Feldmann, Friederike ^b   Brining, Doug ^d   Scott, Dana ^d   LaCasse, Rachel ^d   Geisbert, Joan B ^c,e   Feng, Yan Ru ^f   Chan, Yee Peng ^f   Hickey, Andrew C ^a   Broder, Christopher C ^f   Feldmann, Heinz ^b,g   Geisbert, Thomas W ^c,e  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^f UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^g UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HENDRA VIRUS G GLYCOPROTEIN RECOMBINANT SUBUNIT VACCINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; BRAIN STEM; CHLOROCEBUS; CONTROLLED STUDY; CROSS REACTION; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; HENDRA VIRUS; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INFECTION PREVENTION; LOW DRUG DOSE; LUNG; NIPAH VIRUS; NIPAH VIRUS INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPLEEN; VACCINATION; VIRUS ISOLATION; VIRUS NEUTRALIZATION;

ANIMALS; ANTIGENS, VIRAL; CERCOPITHECUS AETHIOPS; GLYCOPROTEINS; HENDRA VIRUS; HENIPAVIRUS INFECTIONS; NIPAH VIRUS;

EID: 84864851299     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3004241     Document Type: Article

References (35)

1. B. T. Eaton, C. C. Broder, D. Middleton, L.-F. Wang, Hendra and Nipah viruses: Different and dangerous. Nat. Rev. Microbiol. 4, 23-35 (2006).
2. B. T. Eaton, J. S. Mackenzie, L.-F. Wang, Henipaviruses, in Fields Virology, D.M. Knipe, P.M. Howley, Eds. (Lippincott Williams & Wilkins, Philadelphia, 2007), pp. 1587-1600.
3. K. Halpin, A. D.Hyatt, R. Fogarty, D. Middleton, J. Bingham, J. H. Epstein, S. A. Rahman, T.Hughes, C. Smith, H. E. Field, P. Daszak; Henipavirus Ecology Research Group, Pteropid bats are confirmed as the reservoir hosts of henipaviruses: A comprehensive experimental study of virus transmission. Am. J. Trop. Med. Hyg. 85, 946-951 (2011).
4. H. E. Field, J. S. Mackenzie, P. Daszak, Henipaviruses: Emerging paramyxoviruses associated with fruit bats. Curr. Top. Microbiol. Immunol. 315, 133-159 (2007).
5. K. T. Wong, K. C. Ong, Pathology of acute henipavirus infection in humans and animals. Patholog. Res. Int. 2011, 567248 (2011).
6. T. W. Geisbert, H. Feldmann, C. C. Broder, Animal challenge models of Henipavirus infection and pathogenesis. Curr. Top. Microbiol. Immunol. 10.1007/82-2012-208 (2012).
7. C. C. Broder, Henipavirus outbreaks to antivirals: The current status of potential therapeutics. Curr. Opin. Virol. 2, 176-187 (2012).
8. S. P. Luby, M. J. Hossain, E. S. Gurley, B. N. Ahmed, S. Banu, S. U. Khan, N. Homaira, P. A. Rota, P. E. Rollin, J. A. Comer, E. Kenah, T. G. Ksiazek, M. Rahman, Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007. Emerg. Infect. Dis. 15, 1229-1235 (2009).
9. Nipah encephalitis, human-Bangladesh: Jipurhat. ProMED-mail (International Society for Infectious Diseases, 25 January 2012, archive no. 20120125.1022056); http://www. promedmail.org.
10. Hendra virus, human, equine -Australia: Queensland. ProMED-mail (International Society for Infectious Diseases, 20 August 2009, archive no. 20090821.2963); http://www. promedmail.org.
11. E. G. Playford, B. McCall, G. Smith, V. Slinko, G. Allen, I. Smith, F. Moore, C. Taylor, Y. H. Kung, H. Field, Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008. Emerg. Infect. Dis. 16, 219-223 (2010).
12. Hendra virus, equine-Australia (03): Queensland, human exposure. ProMED-mail (International Society for Infectious Diseases, 22 May 2010, archive no. 20100522.1699); http:// www.promedmail.org.
13. Hendra virus, equine-Australia (07): Queensland, New South Wales, human exposure. ProMED-mail (International Society for Infectious Diseases, 6 July 2011, archive no. 20110706.2045); http://www.promedmail.org.
14. Hendra virus, equine-Australia (27): Queensland. ProMED-mail (International Society for Infectious Diseases, 12 October 2011, archive no. 20111012.3057); http://www. promedmail.org.
15. Hendra virus, equine-Australia (19): Queensland, canine. ProMED-mail (International Society for Infectious Diseases, 28 July 2011, archive no. 20110728.2267); http://www.promedmail.org.
16. Hendra virus, equine-Australia: Queensland. ProMED-mail (International Society for Infectious Diseases, 6 January 2012, archive no. 20120106.1001359); http://www.promedmail.org.
17. Hendra virus, equine -Australia (04): Queensland, vaccine research. ProMED-mail (International Society for Infectious Diseases, 1 June 2012, archive no. 20120601.1152600); http:// www.promedmail.org.
18. K. N. Bossart, J. Bingham, D. Middleton, Targeted strategies for Henipavirus therapeutics. Open Virol. J. 1, 14 -25 (2007).
19. K. N. Bossart, G. Crameri, A. S. Dimitrov, B. A. Mungall, Y.-R. Feng, J. R. Patch, A. Choudhary, L.-F. Wang, B. T. Eaton, C. C. Broder, Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus. J. Virol. 79, 6690-6702 (2005).
20. J. A. McEachern, J. Bingham, G. Crameri, D. J. Green, T. J. Hancock, D. Middleton, Y.-R. Feng, C. C. Broder, L.-F. Wang, K. N. Bossart, A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats. Vaccine 26, 3842-3852 (2008).
21. J. Pallister, D. Middleton, L.-F. Wang, R. Klein, J. Haining, R. Robinson, M. Yamada, J. White, J. Payne, Y.-R. Feng, Y.-P. Chan, C. C. Broder, A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge. Vaccine 29, 5623-5630 (2011).
22. K. N. Bossart, J. A. McEachern, A. C. Hickey, V. Choudhry, D. S. Dimitrov, B. T. Eaton, L.-F. Wang, Neutralization assays for differential henipavirus serology using Bio-Plex Protein Array Systems. J. Virol. Methods 142, 29-40 (2007). Downloaded from stm.sciencemag.org on August 9, 2012
23. T. W. Geisbert, K. M. Daddario-DiCaprio, A. C. Hickey, M. A. Smith, Y.-P. Chan, L.-F. Wang, J. J. Mattapallil, J. B. Geisbert, K. N. Bossart, C. C. Broder, Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. PLoS One 5, e10690 (2010).
24. B. Rockx, K. N. Bossart, F. Feldmann, J. B. Geisbert, A. C. Hickey, D. Brining, J. Callison, D. Safronetz, A. Marzi, L. Kercher, D. Long, C. C. Broder, H. Feldmann, T. W. Geisbert, A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment. J. Virol. 84, 9831-9839 (2010).
25. K. N. Bossart, Z. Zhu, D. Middleton, J. Klippel, G. Crameri, J. Bingham, J. A. McEachern, D. Green, T. J. Hancock, Y.-P. Chan, A. C. Hickey, D. S. Dimitrov, L.-F. Wang, C. C. Broder, A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute Nipah virus infection. PLoS Pathog. 5, e1000642 (2009).
26. K. N. Bossart, T. W. Geisbert, H. Feldmann, Z. Zhu, F. Feldmann, J. B. Geisbert, L. Yan, Y.-R. Feng, D. Brining, D. Scott, Y. Wang, A. S. Dimitrov, J. Callison, Y.-P. Chan, A. C. Hickey, D. S. Dimitrov, C. C. Broder, B. Rockx, A neutralizing human monoclonal antibody protects African green monkeys from Hendra virus challenge. Sci. Transl. Med. 3, 105ra103 (2011).
27. K. T. Wong, W.-J. Shieh, S. Kumar, K. Norain, W. Abdullah, J. Guarner, C. S. Goldsmith, K. B. Chua, S. K. Lam, C. T. Tan, K. J. Goh, H. T. Chong, R. Jusoh, P. E. Rollin, T. G. Ksiazek, S. R. Zaki; Nipah Virus Pathology Working Group, Nipah virus infection: Pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am. J. Pathol. 161, 2153-2167 (2002).
28. K. T. Wong, T. Robertson, B. B. Ong, J.W. Chong, K. C. Yaiw, L. F.Wang, A. J. Ansford, A. Tannenberg, Human Hendra virus infection causes acute and relapsing encephalitis. Neuropathol. Appl. Neurobiol. 35, 296-305 (2009).
29. S. P. Luby, M. Rahman, M. J. Hossain, L. S. Blum, M. M. Husain, E. Gurley, R. Khan, B. N. Ahmed, S. Rahman, N. Nahar, E. Kenah, J. A. Comer, T. G. Ksiazek, Foodborne transmission of Nipah virus, Bangladesh. Emerg. Infect. Dis. 12, 1888-1894 (2006).
30. N. Nahar, R. Sultana, E. S. Gurley, M. J. Hossain, S. P. Luby, Date palm sap collection: Exploring opportunities to prevent Nipah transmission. Ecohealth 7, 196-203 (2010).
31. R. Stone, Epidemiology. Breaking the chain in Bangladesh. Science 331, 1128 -1131 (2011).
32. D. H. Mendez, J. Judd, R. Speare, Unexpected result of Hendra virus outbreaks for veterinarians, Queensland, Australia. Emerg. Infect. Dis. 18, 83-85 (2012).
33. M. Balzer, Hendra vaccine success announced. Aust. Vet. J. 89, N2-N3 (2011).
34. C. C. Broder, T. W. Geisbert, K. Xu, D. B. Nikolov, L. F. Wang, D. Middleton, J. Pallister, K. N. Bossart, Immunization strategies against henipaviruses. Curr. Top.Microbiol. Immunol. 10.1007/82-2012-213 (2012).
35. D. L. Brining, J. S. Mattoon, L. Kercher, R. A. LaCasse, D. Safronetz, H. Feldmann, M. J. Parnell, Thoracic radiography as a refinement methodology for the study of H1N1 influenza in cynomologus macaques (Macaca fascicularis). Comp. Med. 60, 389-395 (2010).